Skip to content
Technology Opportunities & Ventures
While focus is on header menu items,
press the down arrow to open sub-menu.

For Innovators

Getting your innovations out into the world and to the people that need them.

In This Section

‹ Home › Startups › Our Startup Portfolio › Inthera Bio

Startups

Inthera Bioscience

Inthera Bio

2014
Active

Principal Investigators: Arora

Inthera Bioscience AG is a Swiss biotech company which develops novel small chemical molecules that act as inhibitors of cellular processes that are essential to tumor cells.

Inthera has selected to target biological characteristics which are of fundamental importance in cancer cells characterized by a high replication and proliferation rate.

Currently in late preclinical development, the lead molecule INTH-454 is a new chemical entity that specifically and effectively targets such tumor cells. INTH-454 inhibits DNA replication, interferes with the control of the cell cycle, and induces DNA damage in tumor cells.